Global Vascular Closure Devices Market to Reach US$ 2.4 Billion by 2032, Propelled by Growing Prevalence of Cardiovascular Diseases

March 14, 2023 | Healthcare

The latest report by IMARC Group, titled “Vascular Closure Devices Market Report by Product (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral Access, Radial Access), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032,” finds that the global vascular closure devices market size reached US$ 1.5 Billion in 2023. Vascular closure devices (VCDs) are medical instruments used to seal small punctures made in the femoral artery of a patient after an angiogram or interventional procedure. These devices are extensively used for patients undergoing catheterization through the femoral route compared to the traditional mechanical compression method. They help reduce the risk of immediate bleeding from the puncture site and help assist a large body habitus, anticoagulation, and antiplatelet therapies. They also minimize the time to hemostasis, lowers patient discomfort associated with prolonged bed rest, prevent femoral artery complications, facilitate patient mobilization, and decrease prolonged hospital stays. As a result, VCDs are widely used in specialty and ambulatory surgery centers, hospitals, and clinics across the globe.


Global Vascular Closure Devices Market Trends:

The market is primarily driven by the expanding healthcare sector and the growing prevalence of obesity, lifestyle diseases, and cardiovascular diseases (CVDs) such as coronary heart, stroke, peripheral arterial, and aortic diseases. In addition, the rising demand for catheterization and interventional procedures for treating and diagnosing CVDs is contributing to the market growth. Moreover, the growing preference for minimally invasive surgeries (MIS), as they offer higher accuracy, speedy recovery, and minimized surgical pain, scarring, injury, and hospital stay, represents another major growth-inducing factor. Besides this, the increasing investment by governments of numerous countries to establish new hospitals and develop innovative technologies is providing a positive thrust to market growth. Along with this, the rising focus of doctors on effective blood loss management in patients during surgical procedures is accelerating the product adoption rate. Furthermore, extensive research and development (R&D) activities and collaboration among leading market players for the commercialization and marketing of devices are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 2.4 Billion by 2032, exhibiting a CAGR of 5.1% during the forecast period (2024-2032).


Market Summary:

  • Based on the product, the market has been segmented into passive approximators (collagen plugs, sealant or gel-based devices, and compression-assist devices), active approximators (suture-based devices and clip-based devices), and external hemostatic devices. At present, passive approximators exhibit a clear dominance in the market.  
  • On the basis of access, the market has been divided into femoral and radial access. Presently, femoral access accounts for the largest market share.
  • Based on the procedure, the market has been bifurcated into interventional cardiology and interventional radiology/vascular surgery. Amongst these, interventional cardiology holds the majority of the total market share.
  • On the basis of end user, the market has been classified into hospitals, ambulatory surgical centers, and others, wherein hospitals represent the leading segment.
  • Region-wise, North America (the United States and Canada) exhibits a clear dominance in the market. Other major regions include Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined in the report, with some of the key players being Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, and Vasorum Ltd.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
 Product Covered
  • Passive Approximators: Collagen Plugs, Sealant or Gel-Based Devices, Compression-Assist Devices
  • Active Approximators: Suture-Based Devices, Clip-Based Devices
  • External Hemostatic Devices
Access Covered Femoral Access, Radial Access
Procedure Covered Interventional Cardiology, Interventional Radiology/Vascular Surgery
End-User Covered Hospitals, Ambulatory Surgical Centers, Others
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Vascular Closure Devices Market to Reach US$ 2.4 Billion by 2032, Propelled by Growing Prevalence of Cardiovascular Diseases
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More